Drugs / JDP-205
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02024152 | Mar → Jul 2011 | urticaria | JDP Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JDP-205 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02024152 ↗ |
| Route | Intravenous | “5 mg and 10 mg intravenous doses” NCT02024152 ↗ |